Skip to main content
Erschienen in: BMC Ophthalmology 1/2011

Open Access 01.12.2011 | Research article

Causes and 3-year-incidence of blindness in Jing-An District, Shanghai, China 2001-2009

verfasst von: Liangcheng Wu, Xinghuai Sun, Xingtao Zhou, Chenghai Weng

Erschienen in: BMC Ophthalmology | Ausgabe 1/2011

Abstract

Background

Registered data can provide valuable information regarding blindness. The purpose of this study was to evaluate the main causes and 3-year incidence of registered blindness in Jing-An district in Shanghai, China.

Methods

Data from the blindness registry (age, gender and cause of visual disability) were collected and analyzed. The prevalence of blindness for 2003, 2007, 2009 and the 3-year incidence of blindness were calculated.

Results

The reported blindness increased significantly from 113.7 per 100,000 in 2003 to 145.8 per 100,000 in 2006 to 165.9 per 100,000 in 2009 (P < 0.05, P < 0.05, respectively). Age significantly affects prevalence; the odd ratios (OR) were 2.57 in the 30 y - 49 y range (P < 0.001), 7.27 in the 50 y - 69 y range (P < 0.001) and 21.2 in the ≥ 70 y (P < 0.001). The 3-year incidence increased from 32.3 per 100,000 in 2001-2003 to 34.2 per 100,000 in 2004-2006 to 40.8 per 100,000 in 2007-2009. The causes of new blindness registered in 2001-2009 were myopic macular degeneration (19.4%), followed by glaucoma (17.7%), age-related macular degeneration (11.8%), optical nerve atrophy (9.4%), retinitis pigmentosa (8.6%), diabetic retinopathy (7.8%) and corneal opacity (5.8%).

Conclusions

The 3-year incidence and prevalence of registered blindness increased in the past 9 years. The leading causes of new blindness were myopic macular degeneration, glaucoma and age-related macular degeneration. The pattern of causes has changed little in the past 9 years and is different from other locations in China. The pattern is similar to that of Taiwan, Hongkong, and Western countries.
Hinweise

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

LW carried out the data collection, performed data analysis and drafted the manuscript. XS participated in the design of the study. XZ and CW participated in the study design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.
Abkürzungen
WHO
The World Health Organization
DPF
Disable Person's Federation
BSCVA
best spectacle corrected visual acuity
UCVA
uncorrected visual acuity
MMD
Myopic macular degeneration
AMD
Age-related macular degeneration
RP
Diagnosis of retinitis pigmentosa.

Background

The World Health Organization (WHO) encourages all countries to monitor the magnitude and causes of visual impairment in order to scrutinize and eliminate avoidable blindness [1]. Registered data can provide valuable information regarding blindness. Blindness registries mainly exist in developed countries and are held by state or partially state funded organizations that provide some kind of assistance to the visually disabled[2]. China is a developing country and cannot provide funds to establish a nationwide networked blindness registry. Also varied socioeconomic conditions affect the development of this project in different regions of China.
Shanghai is the largest metropolis in China and its GDP per capita reached $10,529 USD in 2008[3]. Jing-An district is among the nine downtown districts of Shanghai, where a public welfare system is most developed. Jing-An district established a blindness registry in 1992, which is held by the local Disabled Person's Federation (DPF), which is funded by the local government. Although registration is entirely voluntary, it confers significant practical and monetary benefits. We analyzed the data from the Jing-An district DPF with specific objectives including: (1) to identify the causes of registered blindness and to calculate the gender and age-specific prevalence of blindness; (2) to calculate the 3-year incidence of registered blindness in the most recent 9 years; and (3) to suggest priorities for research and intervention strategies for blindness.

Methods

This study is based on the blindness data of the Jing-An district DPF. Age, gender and cause of visual disability data were collected and analyzed. The prevalence at the end of years 2003, 2007, 2009 and the 3-year incidence of blindness was calculated. The study was performed in accordance with the Declaration of Helsinki for research involving human subjects. The study met all standards for ethical approval in China, and the protocol was approved by the institutional board at the health bureau of Shanghai, China.
The criteria for registering blindness in China are in accordance with the WHO categories of visual impairment, and the category of interest for our study was that the visual impairment was irreversible [4]. Blindness was defined as a best spectacle corrected visual acuity (BSCVA) of less than 3/60 in the better eye, or a corresponding visual field loss to less than 10 degrees in the better eye with best possible correction.
All registered blindness cases need to undergo an assessment of visual impairment. The assessment system has been in place in Jing-An district central hospital from 1992 to the present. In the first 9 years, the causes of blindness were not recorded. From 2001, a comprehensive ocular examination was performed on every applicant including uncorrected visual acuity (UCVA), refraction, BSCVA, ophthalmoscope examination and retinal photography. Visual field tests were performed by a kinetic arctic perimeter (YZ22, 66 Vision Tech. Co., Ltd, China) when visual disability was due to glaucoma, retinitis pigmentosa (RP) and other optic nerve diseases.
The causes of blindness were classified according to the International Classification of Diseases, 10th edition [5]. Myopic macular degeneration (MMD) was considered only in subjects with a refractive error exceeding -6.0 diopters in either eye with one or more of the following ophthalmologic findings: tessellated fundus with yellowish white diffuse or grayish white patchy chorioretinal atrophy, macular hemorrhage or posterior staphyloma [6]. Age-related macular degeneration (AMD) was defined according to the Wisconsin age-related maculopathy grading system [7]. Early AMD was defined by the presence of either soft indistinct drusen or the presence of any type of drusen associated with retinal pigment epithelium depigmentation or increased retinal pigment. Late AMD was defined by the appearance of either exudative macular degeneration or pure geographic atrophy. Glaucoma was defined according to the International Society for Geographical and Epidemiological Ophthalmology classification [8]. Diagnosis of RP was based on night blindness, progressive loss of peripheral visual field, and decreased visual acuity with age, as well as on typical signs observed under fundus examination. The diagnosis of diabetic retinopathy, corneal opacity, and other diseases as causes of blindness followed the ophthalmology practice guidelines edited by the China Academy of Ophthalmology.
Using best judgement, the ophthalmologist attempted to identify the disorder causing the greatest limitation of vision as the cause of blindness. The causes of blindness in both eyes were recorded. When two causes appeared to have an equal contribution to visual impairment for one eye, the primary cause was assigned as the cause of blindness. If cataract was regarded as the main cause of blindness, the patient was referred for surgery and reassessed at least 2 months postoperatively if visual function restored unsatisfactorily.
Statistical analysis was performed using SPSS software version 13 (SPSS, Inc., Chicago, IL). The incidence of blindness caused by some diseases is low and varied in different years in a defined area, so we calculated the 3-year incidence of registered blindness per 100,000 in order to reduce the deviation of incidence in different year. And the prevalence of registered blindness per 100,000 were also calculated. Age was grouped as 1 y - 29 y, 30 y - 49 y, 50 y - 69 y and 70 y or older. Binary logistic regression was used to analyze the factors related to the occurrence of registered blindness. Odds ratios and 95% confidence intervals were determined to describe the influence of age and gender on the prevalence of visual impairment. A Chi-square test was used to analyze the difference between genders. P < 0.05 was considered as statistically significant.

Results

Prevalence and causes

The number of people in the blindness registry increased from 378 in 2003 to 458 in 2006 to 514 in 2009. The reported blindness also increased significantly from 114.7 per 100, 000 in 2003 to 145.8 per 100,000 in 2006 to 165.9 per 100,000 in 2009 (P < 0.05, P < 0.05, respectively). The age-specific prevalence and gender-specific prevalence for 2009 are summarized in Table 1. The association of sex and age with blindness was calculated with a logistic regression model, as shown in Table 2. Gender was not a significant factor, but age significantly affected the prevalence. The odd ratios (OR) were 2.57 in the 30 y - 49 y group (P < 0.001), 7.27 in the 50 y - 69 y group (P < 0.001), and 21.2 in the 70 y or older group (P < 0.001).
Table 1
Prevalence of blindness in Jing-An district, Shanghai, China in 2009
 
Age(yrs)
population
blind
Prevalence
95%CI
     
lower
Upper
FEMALE
 
 
1-29
43152
15
34.8
17.2
52.3
 
30-49
42425
22
51.9
30.2
73.5
 
50-69
47173
109
231.1
187.7
274.4
 
70 or 70+
25822
112
433.7
353.6
513.9
 
Total
158572
258
162.7
142.9
182.5
MALE
      
 
1-29
44153
7
15.9
4.1
27.6
 
30-49
40752
39
95.7
65.7
125.7
 
50-69
47383
87
183.6
145.1
222.2
 
70 or 70+
18893
123
651
536.3
765.7
 
Total
151181
256
169.3
148.6
190.1
TT
      
 
1-29
87305
22
25.2
14.7
35.7
 
30-49
83177
61
73.3
54.9
91.7
 
50-69
94556
196
207.3
178.3
236.3
 
70 or 70+
44715
235
525.6
458.5
592.6
 
Total
309753
514
165.9
151.6
180.3
Table 2
Association of registered blindness with gender and age in Jing-an district in 2009
  
OR
95%CI
P
   
lower
Upper
 
Sex
male
1
   
 
female
0.87
0.73
1.04
0.12
age
1-29
1
   
 
30-49
2.57
2.13
3.11
<0.001
 
50-69
7.27
5.48
9.63
<0.001
 
70 or 70+
21.20
13.69
32.84
<0.001
CI: confidence interval
OR: odds ratio (binary logistic regression)
The leading causes of blindness that were registered in 2001-2009 are summarized in Table 3. The causes of blindness were MMD (19.4%), followed by glaucoma (17.7%), AMD (11.8%), optical nerve atrophy (9.4%), RP (8.6%), diabetic retinopathy (7.8%) and corneal opacity (5.8%).
Table 3
Causes of new registered blindness in Jing-An district, Shanghai, China in 2001-2009
 
2001-2003
2004-2006
2007-2009
Causes
cases
eyes
%
order
Incidence 1/100000
cases
eyes
%
order
Incidence 1/100000
case
eyes
%
order
Incidence 1/100000
MMD
15
29
14.5
2
4.8(2.4,7.3)
17
32
15.1
1
5.5(2.9,8.1)
39
74
26.1
1
12.6(8.6,16.5)
Glaucoma
19
38
19.0
1
6.1(3.4,8.9)
16
32
15.1
1
5.2(2.6,7.7)
28
53
18.7
2
9.0(5.7,12.4)
AMD
13
20
10.0
5
4.2(1.9,6.5)
16
29
13.7
3
5.2(2.6,7.7)
19
33
11.6
3
6.1(3.4,8.9)
RP
6
11
5.5
7
1.9(0.4,3.5)
13
26
12.3
4
4.2(1.9,6.5)
12
23
8.1
4
3.9(1.7,6.1)
Diabetic
8
16
8.0
6
2.6(0.8,4.4)
8
16
7.6
6
2.6(0.8,4.4)
11
22
7.8
5
3.6(1.5,5.6)
CO
3
4
2.0
9
1.0(0,2.1)
10
15
7.1
7
3.2(1.2,5.2)
16
21
7.4
6
5.2(2.6,7.7)
RD
15
27
13.5
3
4.8(2.4,7.3)
5
8
3.8
8
1.6(0.2,3.0)
10
16
5.6
7
3.2(1.2,5.2)
ONA
13
26
13.0
4
4.2(1.9,6.6)
14
25
11.8
5
4.5(2.2,6.9)
7
14
4.9
8
2.3(0.6,3.9)
UVITIS
3
6
3.0
8
1.0(0,2.1)
4
7
3.3
9
1.3(0,2.6)
6
10
3.5
9
1.9(0.4,3.5)
OTHERS
17
23
11.5
 
5.5(2.9.8.1)
12
22
10.4
 
3.9(1.7,6.1)
16
18
6.3
 
5.2(2.6,7.7)
Total
100
200
100.0
 
32.3(25.9,38.6)
106
212
100.0
 
34.2(27.7,40.7)
142
284
100.0
 
45.8(38.3,53.4)
MMD: myopic macular degeneration; AMD: age-related macular degeneration; ONA: optic nerve atrophy; RP: retinitis pigmentosa; CO: corneal opacity; RD: retinal detachment.

3-year incidence

The 3-year incidence of registered blindness increased from 32.3 (range 26.0-38.6) per 100,000 in 2001-2003 to 34.2 (range 20.7-40.7) per 100,000 in 2004-2006 to 40.8 (range 40.1-55.5) per 100,000 in 2007-2009 (Table 4). In the blindness registry, retinal detachment was the third cause in 2001-2003, but became the eighth in 2004-2006 and the seventh cause in 2007-2009. Optic nerve atrophy was the fourth cause of blindness in 2001-2003, and became the seventh cause in 2004-2006 and the eighth cause in 2007-2009. However, AMD was the fifth cause in 2001-2003, the third in 2004-2006, and the third in 2007-2009.
Table 4
Prevalence and 3-years-incidences of blindness in Jing-An district, Shanghai, China.
 
2001-2003
2004-2006
2007-2009
Population(10,000)
33.24
30.96
30.97
Blind
378
458
514
Prevalence rate (95%CI)(1/100,1000)
113.7(102.3-125.2)
147.9(134.4-161.5)
165.9(151.6-180.3)
New blind
100
106
142
3-year-incidence (95%CI) (1/100,1000)
32.3(26.0-38.6)
34.22(27.7-40.7)
47.78(40.1-55.5)

Age and new blindness

The ages of the registered cases of new blindness is summarized in Table 5. The average registered age was 64.19 ± 15.86 y. The average registered age increased from 60.1 ± 17.3 y in 2001-2003 to 65.4 ± 15.2 y in 2004-2006 to 66.1 ± 14.8 y in 2007-2009 (P < 0.05, P < 0.05, respectively). The main reason for the increased age of new blindness was that there was an increase in the age of the registered blind due to MMD, optic nerve atrophy, corneal opacity and AMD.
Table 5
Registered age of new blindness in Jing-An district, Shanghai, China.
 
2001-2009
2001-2003
2004-2006
2007-2009
 
Mean ± 1SD
Mean ± 1SD
Mean ± 1SD
Mean ± 1SD
Glaucoma
67.30 ± 14.61
65.89 ± 14.01
67.94 ± 16.23
67.89 ± 14.52
Diabetic
63.00 ± 13.79
63.38 ± 13.73
58.00 ± 14.14
63.64 ± 14.92
MMD
61.32 ± 12.22
54.60 ± 16.61
61.12 ± 11.36
64.00 ± 9.68*
RP
57.29 ± 13.83
58.00 ± 13.28
59.15 ± 10.16
54.92 ± 17.83
AMD
75.31 ± 9.42
71.00 ± 8.98
77.70 ± 9.28*
75.74 ± 9.31
ONA
59.25 ± 17.43
53.23 ± 19.74
66.69 ± 12.24*
53.43 ± 18.82
CO
67.52 ± 16.55
43.00 ± 33.87
66.40 ± 11.50*
72.81 ± 11.33*
RD
61.97 ± 13.78
57.47 ± 15.58
68.80 ± 8.81
65.30 ± 11.28
UVITIS
62.77 ± 14.93
60.33 ± 14.15
59.25 ± 11.95
66.33 ± 18.45
OTHERS
59.93 ± 23.18
58.44 ± 21.51
54.18 ± 27.03
65.73 ± 22.16
Total
64.19 ± 15.86
60.10 ± 17.29
65.43 ± 15.24*
66.12 ± 14.82*
MMD: myopic macular degeneration; AMD: age-related macular degeneration ONA: optic nerve atrophy; RP: retinitis pigmentosa; CO: corneal opacity; RD: retinal detachment.
*:P < 0.05 compared to in 2001-2003

Discussion

To our knowledge, this is the first report on registered blindness in China. Because of the varied socioeconomic levels in China, and the independence of registries in different regions, it is impossible to obtain a complete national dataset, as well as a complete dataset for Shanghai. We therefore analyzed limited data based on the blindness registry in Jing-An district, Shanghai, China.
The number of people in the blindness registry in Jing-An district has increased by 36% since 2003 and by 13% since 2007. In contrast, the population of the district remained stable. The increase in the prevalence and incidence of blindness during 2001-2009 likely represents increased registration rather than increasing levels of disease, considering the short time period involved. Higher life expectancy in the general population in Shanghai may have contributed as well; according to an official publication of the Shanghai Bureau of Statistics, life expectancy in 2001 was 79.7 y and 81.3 y in 2009[3].
Currently, the overall prevalence of blindness is 0.17% for the total population, 0.21% for ages 50 y - 69 y, and 0.53% for ages 70 y or older. The prevalence in this study is lower than that reported in most studies based on a sample of the population in urban China (Table 6) [6, 919]. This is possibly due to inclusion of blindness due to cataracts in the studies. A recent study showed the prevalence of blindness was 0.61% for ages 70 y or older in Shanghai and 29.4% was due to cataract [17], which is a prevalence rate closer to our results. Another study in Henan province showed that the prevalence of blindness in urban areas was only 0.09% [18]. To our knowledge, there are no data available on the incidence of blindness in China to compare with this study. It is difficult to compare the incidence and prevalence of blindness with other countries because of different definitions of blindness and difference age distributions. The prevalence of registered blindness was 0.17% - 0.22% in Ireland (blindness was defined as BSCVA in the better eye of less than 6/60)2 and 0.26% - 0.32% in Israel (using WHO criteria) [20]. The incidence of registered blindness was 0.036% - 0.029% in Israel (using WHO criteria), 0.02% in Ireland (using US criteria) and 0.012% in southern Germany (blindness was defined as BSCVA in the better eye of less than 1/50) [2022]. In our study, blindness was defined by WHO criteria and cataract was extirpated as the cause of registered blindness. Young babies were also enrolled in this study, which would decrease the prevalence and incidence of blindness.
Table 6
Prevalence of blindness and its causes reported from population based studies in china
Country
Age(yrs)
Prevalence
Main causes
Beijing, China
(Xu L et al.2006)
> = 40
0.3%
Cataract(38.5%); Cornea opacity (15.4%);Myopic macular degeneration(7.7%); Glaucoma(7.7%)
Handan china
(Liang YB et al. 2008)
> = 30
0.5%
Cataract (36.6%);Myopic macular degeneration (19.5%)
Glaucoma(7.3%);Cornea opacity(7.3%)
Taiwan, China
(Hsu WM, et al. 2004)
> = 65
0.59%
Cataract (41.7%);Myopic macular degeneration (12.5%)
AMD(10.4%)
Hongkong, China
(Michon JJ, et al. 2002)
> = 60
1.8%
Cataract (51.7%);Macular degeneration (27.1%)
Glaucoma(7.1%)
Hebei, China
(Song XJ.1992)
 
0.19%
in urban areas
Cataract(32.3%);trachoma complications(13.4%)
corneal disease(13.06%);glaucoma(9.97%)
Shanxi, China
(Zhang JX.1990)
 
0.18%
in cities
Cataract (29.7%)
Shangdong, china
(Yu XM.1992)
 
0.34%
Cataract, corneal diseases and glaucoma in urban areas
China
(Zhang SY.1992)
 
0.43%
Cataract(41.06%);Corneal disease(15,38%)
Trachoma (10.4%);Glaucoma (8.8%)
Chongqing, china
(Liu S, et al. 2007)
>50
1.8%
Cataract (17.9%);Retinal diseases (20.7%); refraction error(15.4%);
cornea disease (11.6%); glaucoma (13.4%)
Shanghai
(Huang XB, et al. 2009)
 
0.95%
in 60-79 yrs
0.68%
in 70-79 yrs
0.40%yrs
in 80 yrs or older
Macular degeneration(28.57%);Cataract(27.27%); Corneal opacity (6.49%);
Retinal detachment (5.84%); Optical nerve atrophy (5.19%); Retinitis pigmentosa (5.19%)
Henan
(Li Y et al.2009)
 
0.09%
in urban
no noted
Hubei
(Chen W et al. 2009)
 
0.33%
in urban
Cataract (54.55%);Glaucoma(10.22%); Congenital abnormal (8.41%);Corneal disease(7.48%); Retinal and choroidal disease (6.54%)
The leading causes of blindness in the present study were MMD (22.6%), glaucoma (18.7%), AMD (11.6%) and RP (8.1%). Some studies showed that corneal opacity was also a major cause of blindness in China (shown in Table 5) [9, 1218]. In the present study corneal opacity was the eighth cause of blindness. Although the number of cases of corneal opacity increased, along with an increase in the registered age from 43.0 ± 33.9 y in 2001-2003 to 72.8 ± 11.3 y in 2007-2009, visual acuity must have been lost in an earlier stage. The reason for this is that infectious keratitis and trachoma have been well controlled in Shanghai. A recent study showed that glaucoma was the eighth cause of blindness and accounted for 4.1% of blindness in Shanghai, whereas it was the second cause at 18.7% in the present study [17]. However, no visual field examinations were performed in their study. AMD has increased dramatically as a cause of blindness. It was the fifth cause in 2001-2003, while it became the third cause in 2007-2008. The pattern of causes of blindness was similar to that in Taiwan, Hongkong, and Western countries [6, 11, 2022]. Glaucoma and AMD have also become the leading causes of blindness in the Jing-An district of Shanghai.
The analysis shows the importance of glaucoma as the leading cause of blindness in China today. Most patients with glaucoma can maintain sufficient visual acuity if effective treatment is given at an early stage, especially for primary angle-closure glaucoma (PACG), which is major category of glaucoma in China. The study showed that 92.86% of blindness due to glaucoma occurred at 51 y or older. We therefore suggest that local health bureaus should conduct glaucoma screening for those aged 51 y or older to diagnose glaucoma at an early stage.
AMD and MMD are the chief causes leading to blindness. Unfortunately, for most people with AMD, vision loss can neither be prevented nor adequately reversed. There is clearly a need for further research on the causes and risk factors of AMD. Persons with MMD will also benefit from the research. Controlling the development of high myopia is impending. Research on the mechanisms of myopia progression is necessary to decrease the vision impairment burden of students.
This study is based on registered data for a defined geographic area. We acknowledge there are some limitations in our study. We had to rely on the limited information from the CDPF, and the causes of blindness registered before 2001 were not recorded. The increase in the prevalence and incidence of blindness likely represents increased registration rather than increasing levels of disease. In this study, the cause of blindness was recorded for each eye, which would increase the proportion of disorders with a bilateral tendency such as AMD, MMD and glaucoma as the cause of blindness. It would be better to record the causes by case. The efficacy of the registration system is not certain. Previous studies in other countries found that only 45% - 60% of eligible patients were registered [23]. It is therefore necessary to make a dedicated effort to evaluate the efficacy of the registry system in China.

Conclusions

The 3-year incidence and reported blind increased in the past 9 years. The leading causes of new cases of blindness that were registered were MMD, glaucoma and AMD. The pattern of causes has changed little in the past 9 years, is different from other locations in China, and is similar to patterns in Taiwan, Hongkong and Western countries.

Acknowledgements

This research was supported by Foundation of Health Science Research of the Health Bureau of Shanghai, China (No.: 2008-161), Shi-Bai-Qian Plans of Jing-An district health bureau, Shanghai, China (2010020103), and the Funds for International Cooperation and Exchange of the National Natural Science Foundation of China (Grant No. 81020108017).
Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( https://​creativecommons.​org/​licenses/​by/​2.​0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

LW carried out the data collection, performed data analysis and drafted the manuscript. XS participated in the design of the study. XZ and CW participated in the study design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.
Literatur
1.
Zurück zum Zitat Resnikoff S, Pascolini D, Kocur I, Pararajasegaram R, Pokharel GP, Mariotti SP: Global data on visual impairment in the year 2002. Bull World Health Org. 2004, 82: 844-51.PubMedPubMedCentral Resnikoff S, Pascolini D, Kocur I, Pararajasegaram R, Pokharel GP, Mariotti SP: Global data on visual impairment in the year 2002. Bull World Health Org. 2004, 82: 844-51.PubMedPubMedCentral
2.
Zurück zum Zitat Munier A, Gunning T, Kenny D, O'Keefe M: Causes of blindness in the adult population of the Republic of Ireland. Br J Ophthalmol. 1998, 82: 630-10.1136/bjo.82.6.630.CrossRefPubMedPubMedCentral Munier A, Gunning T, Kenny D, O'Keefe M: Causes of blindness in the adult population of the Republic of Ireland. Br J Ophthalmol. 1998, 82: 630-10.1136/bjo.82.6.630.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat World Health Organisation: International classification of impairments, disabilities and handicaps. 1980, Geneva: WHO, 79-85. World Health Organisation: International classification of impairments, disabilities and handicaps. 1980, Geneva: WHO, 79-85.
5.
Zurück zum Zitat World Health Organization: Diseases of the eye and adnexa. International statistical classification of diseases and related health problems: ICD-10, tenth revision. 2004, Geneva: World Health Organization, 1: 426-428. World Health Organization: Diseases of the eye and adnexa. International statistical classification of diseases and related health problems: ICD-10, tenth revision. 2004, Geneva: World Health Organization, 1: 426-428.
6.
Zurück zum Zitat Hsu WM, Cheng CY, Liu JH, Tsai SY, Chou P: Prevalence and causes of visual impairment in an elderly Chinese population in Taiwan: the Shihpai Eye Study. Ophthalmology. 2004, 111: 62-9. 10.1016/j.ophtha.2003.05.011.CrossRefPubMed Hsu WM, Cheng CY, Liu JH, Tsai SY, Chou P: Prevalence and causes of visual impairment in an elderly Chinese population in Taiwan: the Shihpai Eye Study. Ophthalmology. 2004, 111: 62-9. 10.1016/j.ophtha.2003.05.011.CrossRefPubMed
7.
Zurück zum Zitat Klein R, Davis MD, Magli YL, Segal P, Klein BE, Hubbard L: The Wisconsin age-related maculopathy grading system. Ophthalmology. 1991, 98: 1128-34.CrossRefPubMed Klein R, Davis MD, Magli YL, Segal P, Klein BE, Hubbard L: The Wisconsin age-related maculopathy grading system. Ophthalmology. 1991, 98: 1128-34.CrossRefPubMed
8.
Zurück zum Zitat Foster PJ, Buhrmann R, Quigley HA, Johnson GJ: The definition and classification of glaucoma in prevalence surveys. Br J Ophthalmol. 2002, 86: 238-42. 10.1136/bjo.86.2.238.CrossRefPubMedPubMedCentral Foster PJ, Buhrmann R, Quigley HA, Johnson GJ: The definition and classification of glaucoma in prevalence surveys. Br J Ophthalmol. 2002, 86: 238-42. 10.1136/bjo.86.2.238.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Xu L, Wang Y, Li Y, Wang Y, Cui T, Li J, Jonas JB: Causes of blindness and visual impairment in urban and rural areas in Beijing: the Beijing Eye Study. Ophthalmology. 2006, 113: 1134-113.PubMed Xu L, Wang Y, Li Y, Wang Y, Cui T, Li J, Jonas JB: Causes of blindness and visual impairment in urban and rural areas in Beijing: the Beijing Eye Study. Ophthalmology. 2006, 113: 1134-113.PubMed
10.
Zurück zum Zitat Liang YB, Friedman DS, Wong TY: Prevalence and causes of low vision and blindness in a rural chinese adult population: the Handan Eye Study. Ophthalmology. 2008, 115: 1965-72. 10.1016/j.ophtha.2008.05.030.CrossRefPubMed Liang YB, Friedman DS, Wong TY: Prevalence and causes of low vision and blindness in a rural chinese adult population: the Handan Eye Study. Ophthalmology. 2008, 115: 1965-72. 10.1016/j.ophtha.2008.05.030.CrossRefPubMed
11.
Zurück zum Zitat Michon JJ, Lau J, Chan WS, Ellwein LB: Prevalence of visual impairment, blindness, and cataract surgery in the Hong Kong elderly. Br J Ophthalmol. 2002, 86: 133-9. 10.1136/bjo.86.2.133.CrossRefPubMedPubMedCentral Michon JJ, Lau J, Chan WS, Ellwein LB: Prevalence of visual impairment, blindness, and cataract surgery in the Hong Kong elderly. Br J Ophthalmol. 2002, 86: 133-9. 10.1136/bjo.86.2.133.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Song XJ: An epidemiological survey of blindness and low vision in Hebei Province. Zhonghua Yan Ke Za Zhi. 1992, 28: 105-7.PubMed Song XJ: An epidemiological survey of blindness and low vision in Hebei Province. Zhonghua Yan Ke Za Zhi. 1992, 28: 105-7.PubMed
13.
Zurück zum Zitat Zhang JX: A survey of blindness and low vision in Shanxi Province. Zhonghua Yan Ke Za Zhi. 1990, 26: 39-42.PubMed Zhang JX: A survey of blindness and low vision in Shanxi Province. Zhonghua Yan Ke Za Zhi. 1990, 26: 39-42.PubMed
14.
Zurück zum Zitat Yu XM: An epidemiological survey of blindness and low vision in Shandong Province. Zhonghua Yan Ke Za Zhi. 1992, 28: 363-6.PubMed Yu XM: An epidemiological survey of blindness and low vision in Shandong Province. Zhonghua Yan Ke Za Zhi. 1992, 28: 363-6.PubMed
15.
Zurück zum Zitat Zhang SY: The 1987 National Epidemiological Survey of Blindness and Low Vision in China. Zhonghua Yan Ke Za Zhi. 1992, 28: 260-4.PubMed Zhang SY: The 1987 National Epidemiological Survey of Blindness and Low Vision in China. Zhonghua Yan Ke Za Zhi. 1992, 28: 260-4.PubMed
16.
Zurück zum Zitat Liu S, Chen L, Ouyang L, Peng Q: The survey of prevalence of blindness in Nan'an District of Chongqing. Zhonghua Yan Ke Za Zhi. 2007, 43: 722-5.PubMed Liu S, Chen L, Ouyang L, Peng Q: The survey of prevalence of blindness in Nan'an District of Chongqing. Zhonghua Yan Ke Za Zhi. 2007, 43: 722-5.PubMed
17.
Zurück zum Zitat Huang XB, Zou HD, Wang N: A prevalence survey of blindness and visual impairment in adults aged equal or more than 60 years in Beixinjing blocks of Shanghai, China. Zhonghua Yan Ke Za Zhi. 2009, 45: 786-92.PubMed Huang XB, Zou HD, Wang N: A prevalence survey of blindness and visual impairment in adults aged equal or more than 60 years in Beixinjing blocks of Shanghai, China. Zhonghua Yan Ke Za Zhi. 2009, 45: 786-92.PubMed
18.
Zurück zum Zitat Li YY, Zhu Y, Li ZG, Chen P, Yan SJ: A cross-sectional study on the visual disability of the residents in 2006 in Henan province, China. Zhonghua Yan Ke Za Zhi. 2009, 45: 781-5.PubMed Li YY, Zhu Y, Li ZG, Chen P, Yan SJ: A cross-sectional study on the visual disability of the residents in 2006 in Henan province, China. Zhonghua Yan Ke Za Zhi. 2009, 45: 781-5.PubMed
19.
Zurück zum Zitat Chen W, Liu J, Lu YH, Hu YZ, Lu YX, You CJ: A cross-sectional study on the prevalence of visual impairment in 2006 in Hubei province, China. Zhonghua Yan Ke Za Zhi. 2009, 45: 776-80.PubMed Chen W, Liu J, Lu YH, Hu YZ, Lu YX, You CJ: A cross-sectional study on the prevalence of visual impairment in 2006 in Hubei province, China. Zhonghua Yan Ke Za Zhi. 2009, 45: 776-80.PubMed
20.
Zurück zum Zitat Avisar R, Friling R, Snir M, Avisar I, Weinberger D: Estimation of prevalence and incidence rates and causes of blindness in Israel, 1998-2003. Isr Med Assoc J. 2006, 8: 880-1.PubMed Avisar R, Friling R, Snir M, Avisar I, Weinberger D: Estimation of prevalence and incidence rates and causes of blindness in Israel, 1998-2003. Isr Med Assoc J. 2006, 8: 880-1.PubMed
21.
Zurück zum Zitat Kelliher C, Kenny D, O'Brien C: Trends in blind registration in the adult population of the Republic of Ireland 1996-2003. Br J Ophthalmol. 2006, 90: 367-71. 10.1136/bjo.2005.075861.CrossRefPubMedPubMedCentral Kelliher C, Kenny D, O'Brien C: Trends in blind registration in the adult population of the Republic of Ireland 1996-2003. Br J Ophthalmol. 2006, 90: 367-71. 10.1136/bjo.2005.075861.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Trautner C, Haastert B, Richter B, Berger M, Giani G: Incidence of blindness in southern Germany due to glaucoma and degenerative conditions. Invest Ophthalmol Vis Sci. 2003, 44: 1031-1034. 10.1167/iovs.02-0304.CrossRefPubMed Trautner C, Haastert B, Richter B, Berger M, Giani G: Incidence of blindness in southern Germany due to glaucoma and degenerative conditions. Invest Ophthalmol Vis Sci. 2003, 44: 1031-1034. 10.1167/iovs.02-0304.CrossRefPubMed
23.
Zurück zum Zitat Bunc C, Evans J, Frase S, Wormald R: BD8 certification of visually impaired people. Br J Ophthalmol. 1998, 82: 72-76. 10.1136/bjo.82.1.72.CrossRef Bunc C, Evans J, Frase S, Wormald R: BD8 certification of visually impaired people. Br J Ophthalmol. 1998, 82: 72-76. 10.1136/bjo.82.1.72.CrossRef
24.
Zurück zum Zitat Barry RJ, Murray PI: Unregistered visual impairment: is registration a failing system?. Br J Ophthalmol. 2005, 89: 995-8. 10.1136/bjo.2004.059915.CrossRefPubMedPubMedCentral Barry RJ, Murray PI: Unregistered visual impairment: is registration a failing system?. Br J Ophthalmol. 2005, 89: 995-8. 10.1136/bjo.2004.059915.CrossRefPubMedPubMedCentral
Metadaten
Titel
Causes and 3-year-incidence of blindness in Jing-An District, Shanghai, China 2001-2009
verfasst von
Liangcheng Wu
Xinghuai Sun
Xingtao Zhou
Chenghai Weng
Publikationsdatum
01.12.2011
Verlag
BioMed Central
Erschienen in
BMC Ophthalmology / Ausgabe 1/2011
Elektronische ISSN: 1471-2415
DOI
https://doi.org/10.1186/1471-2415-11-10

Weitere Artikel der Ausgabe 1/2011

BMC Ophthalmology 1/2011 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.